{"id":521157,"date":"2021-08-02T08:03:53","date_gmt":"2021-08-02T12:03:53","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/enlivex-hires-biotech-industry-veteran-tzvi-palash-to-lead-the-design-and-construction-of-its-new-cgmp-allocetra-manufacturing-plant\/"},"modified":"2021-08-02T08:03:53","modified_gmt":"2021-08-02T12:03:53","slug":"enlivex-hires-biotech-industry-veteran-tzvi-palash-to-lead-the-design-and-construction-of-its-new-cgmp-allocetra-manufacturing-plant","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/enlivex-hires-biotech-industry-veteran-tzvi-palash-to-lead-the-design-and-construction-of-its-new-cgmp-allocetra-manufacturing-plant\/","title":{"rendered":"Enlivex Hires Biotech Industry Veteran Tzvi Palash to Lead the Design and Construction of its New cGMP Allocetra Manufacturing Plant"},"content":{"rendered":"
\n

\n
\n Mr. Palash joins Enlivex from Gamida Cell, where he served as Chief Operating Officer, and previously served as Chief Operating Officer of Protalix Biotherapeutics, and as General Manager of ColBar LifeScience, a Johnson & Johnson company<\/em>
\n <\/strong>\n <\/p>\n

\n Nes Ziona, Israel, Aug. 02, 2021 (GLOBE NEWSWIRE) — <\/strong>Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the \u201cCompany\u201d), a clinical-stage macrophage reprogramming immunotherapy company, today announced the hiring of Tzvi Palash as Project Lead to manage the design and construction of the Company\u2019s new cGMP AllocetraTM<\/sup> manufacturing plant.<\/p>\n

\u201cTzvi is a highly talented industry veteran, and we are thrilled that he is joining our team,\u201d said Oren Hershkovitz, Ph.D., Chief Executive Officer of Enlivex. \u201cHe has successfully led the construction of multiple manufacturing plants, with experience specifically in the cell therapy space, leaving him well suited for his new role. I look forward to working with him to increase our manufacturing capacity in preparation for upcoming clinical trials and the potential commercialization of AllocetraTM<\/sup>, if approved.\u201d<\/p>\n

Mr. Palash brings over 35 years of experience in the healthcare industry to Enlivex and has extensive expertise leading the construction of pharmaceutical manufacturing plants. Mr. Palash joins Enlivex from Gamida Cell where, as Chief Operating Officer (COO), he was responsible for overseeing operational activities including the recently completed construction of a cell therapy manufacturing plant. Prior to that, Mr. Palash was the COO of Protalix Biotherapeutics, Inc., where he led all operational activities through the approval of Elelyso\u00ae, the company\u2019s plant cell culture-derived protein product, by the U.S. Food and Drug Administration (FDA). Prior to joining Protalix, Mr. Palash led the planning, construction, scale-up and regulatory oversight of an Israel-based manufacturing facility as a COO and General Manager at ColBar LifeScience Ltd, a biomaterials company acquired by Johnson & Johnson. He also successfully led FDA audits for Evolence\u00ae and Ossix\u00ae, and was a member of the Global Aesthetic Management Team within the Consumer Group of Johnson & Johnson. Earlier in his career, Mr. Palash held operational roles at Teva Pharmaceutical Industries and Interpham Laboratories.<\/p>\n

Mr. Palash added, \u201cThe opportunity to lead the design and construction of Enlivex\u2019s new manufacturing plant is truly exciting. I believe that the Company has generated compelling clinical data in sepsis and COVID-19, preclinical data in solid tumors, and Allocetra\u2019s broadly applicable mechanism of action positions Enlivex as a future leader in cell therapies for infectious, inflammatory and oncologic diseases. I am eager to begin working with my new colleagues and believe that our complementary skill sets will serve us well as we continue to advance AllocetraTM<\/sup>\u2019s development.\u201d<\/p>\n

\n ABOUT ALLOCETRA<\/strong>
\n
\n TM<\/strong>
\n <\/sup>\n <\/p>\n

AllocetraTM<\/sup> is being developed as a universal, off-the-shelf cell therapy designed to\u00a0reprogram macrophages into their homeostatic state. Diseases such as solid cancers, sepsis, COVID-19 and many others reprogram macrophages out of their homeostatic state. These non-homeostatic macrophages contribute significantly to the severity of the respective diseases. By restoring macrophage homeostasis, AllocetraTM<\/sup> has the potential to provide a novel immunotherapeutic mechanism of action\u00a0for life-threatening clinical indications that are defined as \u201cunmet medical needs\u201d, as a stand-alone therapy or in combination with leading therapeutic agents.<\/p>\n

\n ABOUT <\/strong>
\n ENLIVEX<\/strong>\n <\/p>\n

Enlivex is a clinical stage immunotherapy company developing AllocetraTM<\/sup>, a universal, off-the-shelf cell therapy designed to\u00a0reprogram macrophages into their homeostatic state. Resetting non-homeostatic macrophages into their homeostatic state is critical for immune system rebalancing and resolution of life-threatening conditions. For more information, visit\u00a0http:\/\/www.enlivex.com.<\/a><\/p>\n

\n Safe Harbor Statement:\u00a0 This press release contains forward-looking statements, which may be identified by words such as \u201cexpects,\u201d \u201cplans,\u201d \u201cprojects,\u201d \u201cwill,\u201d \u201cmay,\u201d \u201canticipates,\u201d \u201cbelieves,\u201d \u201cshould,\u201d \u201cwould\u201d, \u201ccould,\u201d \u201cintends,\u201d \u201cestimates,\u201d \u201csuggests,\u201d \u201chas the potential to\u201d and other words of similar meaning, including statements regarding expected cash balances, market opportunities for the results of current clinical studies and preclinical experiments, the effectiveness of, and market opportunities for, ALLOCETRA<\/em>
\n
\n TM<\/em>
\n <\/sup>
\n \u00a0programs. All such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.\u00a0 Investors are cautioned that forward-looking statements involve risks and uncertainties that may affect <\/em>
\n Enlivex\u2019s<\/em>
\n business and prospects, including the risks that <\/em>
\n Enlivex<\/em>
\n may not succeed in generating any revenues or developing any commercial products; that the products in development may fail, may not achieve the expected results or effectiveness and\/or may not generate data that would support the approval or marketing of these products for the indications being studied or for other indications; that ongoing studies may not continue to show substantial or any activity; and other risks and uncertainties that may cause results to differ materially from those set forth in the forward-looking statements. The results of clinical trials in humans may produce results that differ significantly from the results of clinical and other trials in animals. The results of early-stage trials may differ significantly from the results of more developed, later-stage trials. The development of any products using the ALLOCETRA<\/em>
\n
\n TM<\/em>
\n <\/sup>
\n \u00a0product line could also be affected by <\/em>
\n a number of<\/em>
\n other factors, including unexpected safety, efficacy or manufacturing issues, additional time requirements for data analyses and decision making, the impact of pharmaceutical industry regulation, the impact of competitive products and pricing and the impact of patents and other proprietary rights held by competitors and other third parties.\u00a0 In addition to the risk factors described above, investors should consider the economic, competitive, governmental, <\/em>
\n technological<\/em>
\n and other factors discussed in <\/em>
\n Enlivex\u2019s<\/em>
\n filings with the Securities and Exchange Commission, including in the Company\u2019s most recent Annual Report on Form 20-F filed with the Securities and Exchange Commission.\u00a0 The forward-looking statements contained in this press release speak only as of the date the statements were made, and we do not undertake any obligation to update forward-looking statements, except as required under applicable law.<\/em>\n <\/p>\n

\n ENLIVEX CONTACT<\/strong>
\n
Shachar Shlosberger, CFO
Enlivex Therapeutics, Ltd.
shachar@enlivexpharm.com<\/a><\/p>\n

\n INVESTOR RELATIONS CONTACT<\/strong>
\n
Eric Ribner
LifeSci Advisors
eric@lifesciadvisors.com<\/p>\n

\n \n <\/p>\n<\/p>\n<\/p>\n


\n
\n \n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

Mr. Palash joins Enlivex from Gamida Cell, where he served as Chief Operating Officer, and previously served as Chief Operating Officer of Protalix Biotherapeutics, and as General Manager of ColBar LifeScience, a Johnson & Johnson company Nes Ziona, Israel, Aug. 02, 2021 (GLOBE NEWSWIRE) — Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the \u201cCompany\u201d), a clinical-stage macrophage reprogramming immunotherapy company, today announced the hiring of Tzvi Palash as Project Lead to manage the design and construction of the Company\u2019s new cGMP AllocetraTM manufacturing plant. \u201cTzvi is a highly talented industry veteran, and we are thrilled that he is joining our team,\u201d said Oren Hershkovitz, Ph.D., Chief Executive Officer of Enlivex. \u201cHe has successfully led the construction of multiple manufacturing plants, with experience … <\/p>\n

Continue reading “Enlivex Hires Biotech Industry Veteran Tzvi Palash to Lead the Design and Construction of its New cGMP Allocetra Manufacturing Plant”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-521157","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nEnlivex Hires Biotech Industry Veteran Tzvi Palash to Lead the Design and Construction of its New cGMP Allocetra Manufacturing Plant - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/enlivex-hires-biotech-industry-veteran-tzvi-palash-to-lead-the-design-and-construction-of-its-new-cgmp-allocetra-manufacturing-plant\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Enlivex Hires Biotech Industry Veteran Tzvi Palash to Lead the Design and Construction of its New cGMP Allocetra Manufacturing Plant - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Mr. Palash joins Enlivex from Gamida Cell, where he served as Chief Operating Officer, and previously served as Chief Operating Officer of Protalix Biotherapeutics, and as General Manager of ColBar LifeScience, a Johnson & Johnson company Nes Ziona, Israel, Aug. 02, 2021 (GLOBE NEWSWIRE) — Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the \u201cCompany\u201d), a clinical-stage macrophage reprogramming immunotherapy company, today announced the hiring of Tzvi Palash as Project Lead to manage the design and construction of the Company\u2019s new cGMP AllocetraTM manufacturing plant. \u201cTzvi is a highly talented industry veteran, and we are thrilled that he is joining our team,\u201d said Oren Hershkovitz, Ph.D., Chief Executive Officer of Enlivex. \u201cHe has successfully led the construction of multiple manufacturing plants, with experience … Continue reading "Enlivex Hires Biotech Industry Veteran Tzvi Palash to Lead the Design and Construction of its New cGMP Allocetra Manufacturing Plant"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/enlivex-hires-biotech-industry-veteran-tzvi-palash-to-lead-the-design-and-construction-of-its-new-cgmp-allocetra-manufacturing-plant\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-08-02T12:03:53+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMwMDgwNyM0MzM1ODgyIzUwMDA2NTE3NA==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/enlivex-hires-biotech-industry-veteran-tzvi-palash-to-lead-the-design-and-construction-of-its-new-cgmp-allocetra-manufacturing-plant\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/enlivex-hires-biotech-industry-veteran-tzvi-palash-to-lead-the-design-and-construction-of-its-new-cgmp-allocetra-manufacturing-plant\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Enlivex Hires Biotech Industry Veteran Tzvi Palash to Lead the Design and Construction of its New cGMP Allocetra Manufacturing Plant\",\"datePublished\":\"2021-08-02T12:03:53+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/enlivex-hires-biotech-industry-veteran-tzvi-palash-to-lead-the-design-and-construction-of-its-new-cgmp-allocetra-manufacturing-plant\\\/\"},\"wordCount\":987,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/enlivex-hires-biotech-industry-veteran-tzvi-palash-to-lead-the-design-and-construction-of-its-new-cgmp-allocetra-manufacturing-plant\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMwMDgwNyM0MzM1ODgyIzUwMDA2NTE3NA==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/enlivex-hires-biotech-industry-veteran-tzvi-palash-to-lead-the-design-and-construction-of-its-new-cgmp-allocetra-manufacturing-plant\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/enlivex-hires-biotech-industry-veteran-tzvi-palash-to-lead-the-design-and-construction-of-its-new-cgmp-allocetra-manufacturing-plant\\\/\",\"name\":\"Enlivex Hires Biotech Industry Veteran Tzvi Palash to Lead the Design and Construction of its New cGMP Allocetra Manufacturing Plant - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/enlivex-hires-biotech-industry-veteran-tzvi-palash-to-lead-the-design-and-construction-of-its-new-cgmp-allocetra-manufacturing-plant\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/enlivex-hires-biotech-industry-veteran-tzvi-palash-to-lead-the-design-and-construction-of-its-new-cgmp-allocetra-manufacturing-plant\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMwMDgwNyM0MzM1ODgyIzUwMDA2NTE3NA==\",\"datePublished\":\"2021-08-02T12:03:53+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/enlivex-hires-biotech-industry-veteran-tzvi-palash-to-lead-the-design-and-construction-of-its-new-cgmp-allocetra-manufacturing-plant\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/enlivex-hires-biotech-industry-veteran-tzvi-palash-to-lead-the-design-and-construction-of-its-new-cgmp-allocetra-manufacturing-plant\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/enlivex-hires-biotech-industry-veteran-tzvi-palash-to-lead-the-design-and-construction-of-its-new-cgmp-allocetra-manufacturing-plant\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMwMDgwNyM0MzM1ODgyIzUwMDA2NTE3NA==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMwMDgwNyM0MzM1ODgyIzUwMDA2NTE3NA==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/enlivex-hires-biotech-industry-veteran-tzvi-palash-to-lead-the-design-and-construction-of-its-new-cgmp-allocetra-manufacturing-plant\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Enlivex Hires Biotech Industry Veteran Tzvi Palash to Lead the Design and Construction of its New cGMP Allocetra Manufacturing Plant\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Enlivex Hires Biotech Industry Veteran Tzvi Palash to Lead the Design and Construction of its New cGMP Allocetra Manufacturing Plant - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/enlivex-hires-biotech-industry-veteran-tzvi-palash-to-lead-the-design-and-construction-of-its-new-cgmp-allocetra-manufacturing-plant\/","og_locale":"en_US","og_type":"article","og_title":"Enlivex Hires Biotech Industry Veteran Tzvi Palash to Lead the Design and Construction of its New cGMP Allocetra Manufacturing Plant - Market Newsdesk","og_description":"Mr. Palash joins Enlivex from Gamida Cell, where he served as Chief Operating Officer, and previously served as Chief Operating Officer of Protalix Biotherapeutics, and as General Manager of ColBar LifeScience, a Johnson & Johnson company Nes Ziona, Israel, Aug. 02, 2021 (GLOBE NEWSWIRE) — Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the \u201cCompany\u201d), a clinical-stage macrophage reprogramming immunotherapy company, today announced the hiring of Tzvi Palash as Project Lead to manage the design and construction of the Company\u2019s new cGMP AllocetraTM manufacturing plant. \u201cTzvi is a highly talented industry veteran, and we are thrilled that he is joining our team,\u201d said Oren Hershkovitz, Ph.D., Chief Executive Officer of Enlivex. \u201cHe has successfully led the construction of multiple manufacturing plants, with experience … Continue reading \"Enlivex Hires Biotech Industry Veteran Tzvi Palash to Lead the Design and Construction of its New cGMP Allocetra Manufacturing Plant\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/enlivex-hires-biotech-industry-veteran-tzvi-palash-to-lead-the-design-and-construction-of-its-new-cgmp-allocetra-manufacturing-plant\/","og_site_name":"Market Newsdesk","article_published_time":"2021-08-02T12:03:53+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMwMDgwNyM0MzM1ODgyIzUwMDA2NTE3NA==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/enlivex-hires-biotech-industry-veteran-tzvi-palash-to-lead-the-design-and-construction-of-its-new-cgmp-allocetra-manufacturing-plant\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/enlivex-hires-biotech-industry-veteran-tzvi-palash-to-lead-the-design-and-construction-of-its-new-cgmp-allocetra-manufacturing-plant\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Enlivex Hires Biotech Industry Veteran Tzvi Palash to Lead the Design and Construction of its New cGMP Allocetra Manufacturing Plant","datePublished":"2021-08-02T12:03:53+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/enlivex-hires-biotech-industry-veteran-tzvi-palash-to-lead-the-design-and-construction-of-its-new-cgmp-allocetra-manufacturing-plant\/"},"wordCount":987,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/enlivex-hires-biotech-industry-veteran-tzvi-palash-to-lead-the-design-and-construction-of-its-new-cgmp-allocetra-manufacturing-plant\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMwMDgwNyM0MzM1ODgyIzUwMDA2NTE3NA==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/enlivex-hires-biotech-industry-veteran-tzvi-palash-to-lead-the-design-and-construction-of-its-new-cgmp-allocetra-manufacturing-plant\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/enlivex-hires-biotech-industry-veteran-tzvi-palash-to-lead-the-design-and-construction-of-its-new-cgmp-allocetra-manufacturing-plant\/","name":"Enlivex Hires Biotech Industry Veteran Tzvi Palash to Lead the Design and Construction of its New cGMP Allocetra Manufacturing Plant - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/enlivex-hires-biotech-industry-veteran-tzvi-palash-to-lead-the-design-and-construction-of-its-new-cgmp-allocetra-manufacturing-plant\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/enlivex-hires-biotech-industry-veteran-tzvi-palash-to-lead-the-design-and-construction-of-its-new-cgmp-allocetra-manufacturing-plant\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMwMDgwNyM0MzM1ODgyIzUwMDA2NTE3NA==","datePublished":"2021-08-02T12:03:53+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/enlivex-hires-biotech-industry-veteran-tzvi-palash-to-lead-the-design-and-construction-of-its-new-cgmp-allocetra-manufacturing-plant\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/enlivex-hires-biotech-industry-veteran-tzvi-palash-to-lead-the-design-and-construction-of-its-new-cgmp-allocetra-manufacturing-plant\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/enlivex-hires-biotech-industry-veteran-tzvi-palash-to-lead-the-design-and-construction-of-its-new-cgmp-allocetra-manufacturing-plant\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMwMDgwNyM0MzM1ODgyIzUwMDA2NTE3NA==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMwMDgwNyM0MzM1ODgyIzUwMDA2NTE3NA=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/enlivex-hires-biotech-industry-veteran-tzvi-palash-to-lead-the-design-and-construction-of-its-new-cgmp-allocetra-manufacturing-plant\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Enlivex Hires Biotech Industry Veteran Tzvi Palash to Lead the Design and Construction of its New cGMP Allocetra Manufacturing Plant"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/521157","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=521157"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/521157\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=521157"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=521157"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=521157"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}